LifeMD, Inc. — Director's Dealing 2017

Nov 13, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Kalkstein Robert L (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$0.4	2027-09-30	Common Stock, par value $0.01 (150000)		Direct